Taken together, these observations potentially point to an interplay between CD4 T cells (potentially regulatory T cells) and effector cells (i.e., CD8 T cells and NK cells) that emphasizes the importance of CD8 T cell activity as the main mediator of IL-12 anti-tumor activity. The gene discussed is CD4; the disease is neoplasm.